Sihuan Pharmaceutical Holdings Group Ltd. (HKG:0460)

Hong Kong · Delayed Price · Currency is HKD

1.390

+0.080 (6.11%)

Apr 21, 2026, 4:08 PM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Generic Medicine	956.32M	1.10B	1.40B	1.97B	2.60B
Generic Medicine Growth	-13.01%	-21.41%	-29.01%	-24.16%	18.19%
Innovative Medicine and Other Medicine	232.42M	109.67M	36.77M	165.71M	105.11M
Innovative Medicine and Other Medicine Growth	111.93%	198.24%	-77.81%	57.65%	-76.78%
Medical Aesthetic Products	1.49B	744.22M	449.91M	149.78M	398.95M
Medical Aesthetic Products Growth	99.57%	65.42%	200.38%	-62.46%	1384.92%
Elimination of Intersegment Sales	-56.00M	-52.08M	-24.99M	-104.80M	-63.81M
Total	2.62B	1.90B	1.86B	2.18B	3.04B
Total Growth	37.71%	2.18%	-14.70%	-28.21%	23.30%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Mainland China	2.60B	1.89B	1.85B	2.17B	3.04B
Mainland China Growth	37.91%	2.26%	-14.77%	-28.69%	23.30%
United States of America	13.10M	12.56M	13.79M	14.41M	-
United States of America Growth	4.30%	-8.89%	-4.28%	-	-
Others	342.00K	-	-	-	-
Total	2.62B	1.90B	1.86B	2.18B	3.04B
Total Growth	37.71%	2.18%	-14.70%	-28.21%	23.30%

Source: S&P Global Market Intelligence.